UTI

SEC source: 0001209191-17-053361 · doc4.xml · nonDerivative · entry 2

Freed Chad Allen · CIK 0001319172 · EVP, Gen Counsel & Corp Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,506

F2 · shares: Vesting of Restricted Stock Units granted on 09/16/2015. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-053380 · doc4.xml · nonDerivative · entry 2

Peterson Bryce H · CIK 0001537809 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,604

F2 · shares: Vesting of Restricted Stock Units granted on 09/16/2015. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-053378 · doc4.xml · nonDerivative · entry 2

Smith Sherrell · CIK 0001371105 · EVP, Admissions and Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,223

F2 · shares: Vesting of Restricted Stock Units granted on 09/16/2015. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-053376 · doc4.xml · nonDerivative · entry 1

Turner Rhonda R · CIK 0001493754 · SVP People Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,466

F1 · shares: Vesting of Restricted Stock granted on 09/14/2016. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-053374 · doc4.xml · nonDerivative · entry 1

MCWATERS KIMBERLY J · CIK 0001272480 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 594,107

F1 · shares: Vesting of Restricted Stock granted on 09/14/2016. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-053361 · doc4.xml · nonDerivative · entry 1

Freed Chad Allen · CIK 0001319172 · EVP, Gen Counsel & Corp Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,974

F1 · shares: Vesting of Restricted Stock granted on 09/14/2016. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-053380 · doc4.xml · nonDerivative · entry 1

Peterson Bryce H · CIK 0001537809 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,399

F1 · shares: Vesting of Restricted Stock granted on 09/14/2016. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-053378 · doc4.xml · nonDerivative · entry 1

Smith Sherrell · CIK 0001371105 · EVP, Admissions and Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,735

F1 · shares: Vesting of Restricted Stock granted on 09/14/2016. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-053184 · doc4.xml · nonDerivative · entry 1

MCWATERS KIMBERLY J · CIK 0001272480 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 613,295

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2017.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.33 to $3.40, inclusive. The reporting person undertakes to provide to Universal Technical Institute, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

SEC source: 0001209191-17-053083 · doc4.xml · derivative · entry 2

Turner Rhonda R · CIK 0001493754 · SVP People Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Cash · Not disclosed shares

Expires 2019-09-13

F2 · derivative.exercise_price: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F2 · derivative.exercise_date: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F2 · underlyingValue: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

SEC source: 0001209191-17-053083 · doc4.xml · derivative · entry 1

Turner Rhonda R · CIK 0001493754 · SVP People Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,095

Underlying: Common Stock · 17,095 shares

Expires 2019-09-13

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the Company's common stock, which vests based on the 2-year compound annual total shareholder return ("TSR"). For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the Company's common stock, which vests based on the 2-year compound annual total shareholder return ("TSR"). For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

SEC source: 0001209191-17-053080 · doc4.xml · derivative · entry 2

MCWATERS KIMBERLY J · CIK 0001272480 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Cash · Not disclosed shares

Expires 2019-09-13

F2 · derivative.exercise_price: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F2 · derivative.exercise_date: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F2 · underlyingValue: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

SEC source: 0001209191-17-053080 · doc4.xml · derivative · entry 1

MCWATERS KIMBERLY J · CIK 0001272480 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,471

Underlying: Common Stock · 85,471 shares

Expires 2019-09-13

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the Company's common stock, which vests based on the 2-year compound annual total shareholder return ("TSR"). For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the Company's common stock, which vests based on the 2-year compound annual total shareholder return ("TSR"). For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

SEC source: 0001209191-17-053082 · doc4.xml · derivative · entry 2

Smith Sherrell · CIK 0001371105 · EVP, Admissions and Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Cash · Not disclosed shares

Expires 2019-09-13

F2 · derivative.exercise_price: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F2 · derivative.exercise_date: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F2 · underlyingValue: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

SEC source: 0001209191-17-053082 · doc4.xml · derivative · entry 1

Smith Sherrell · CIK 0001371105 · EVP, Admissions and Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,710

Underlying: Common Stock · 26,710 shares

Expires 2019-09-13

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the Company's common stock, which vests based on the 2-year compound annual total shareholder return ("TSR"). For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the Company's common stock, which vests based on the 2-year compound annual total shareholder return ("TSR"). For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

SEC source: 0001209191-17-053081 · doc4.xml · derivative · entry 2

Peterson Bryce H · CIK 0001537809 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Cash · Not disclosed shares

Expires 2019-09-13

F2 · derivative.exercise_price: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F2 · derivative.exercise_date: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F2 · underlyingValue: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

SEC source: 0001209191-17-053081 · doc4.xml · derivative · entry 1

Peterson Bryce H · CIK 0001537809 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,909

Underlying: Common Stock · 25,909 shares

Expires 2019-09-13

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the Company's common stock, which vests based on the 2-year compound annual total shareholder return ("TSR"). For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the Company's common stock, which vests based on the 2-year compound annual total shareholder return ("TSR"). For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

SEC source: 0001209191-17-053078 · doc4.xml · derivative · entry 2

Jameson Piper P · CIK 0001534143 · EVP & Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Cash · Not disclosed shares

Expires 2019-09-13

F2 · derivative.exercise_price: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F2 · derivative.exercise_date: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F2 · underlyingValue: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

SEC source: 0001209191-17-053078 · doc4.xml · derivative · entry 1

Jameson Piper P · CIK 0001534143 · EVP & Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,581

Underlying: Common Stock · 15,581 shares

Expires 2019-09-13

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the Company's common stock, which vests based on the 2-year compound annual total shareholder return ("TSR"). For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the Company's common stock, which vests based on the 2-year compound annual total shareholder return ("TSR"). For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

SEC source: 0001209191-17-053077 · doc4.xml · derivative · entry 2

Freed Chad Allen · CIK 0001319172 · EVP, Gen Counsel & Corp Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Cash · Not disclosed shares

Expires 2019-09-13

F2 · derivative.exercise_price: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F2 · reported_value: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F2 · derivative.exercise_date: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F2 · derivative.underlying: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F2 · underlyingValue: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F2 · valueOwnedAfter: Represents a contingent right to receive cash, which vests based on the 2-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

SEC source: 0001209191-17-053077 · doc4.xml · derivative · entry 1

Freed Chad Allen · CIK 0001319172 · EVP, Gen Counsel & Corp Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,710

Underlying: Common Stock · 26,710 shares

Expires 2019-09-13

F1 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the Company's common stock, which vests based on the 2-year compound annual total shareholder return ("TSR"). For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

F1 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the Company's common stock, which vests based on the 2-year compound annual total shareholder return ("TSR"). For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second anniversary of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

SEC source: 0001209191-17-051921 · doc4.xml · nonDerivative · entry 2

Turner Rhonda R · CIK 0001493754 · SVP People Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,258

F2 · shares: Vesting of Restricted Stock Units granted on 09/05/2013. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-051973 · doc4.xml · nonDerivative · entry 2

MCWATERS KIMBERLY J · CIK 0001272480 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 608,264

F2 · shares: Vesting of Restricted Stock Units granted on 09/05/2013. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-051958 · doc4.xml · nonDerivative · entry 2

Freed Chad Allen · CIK 0001319172 · EVP, Gen Counsel & Corp Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,201

F2 · shares: Vesting of Restricted Stock Units granted on 09/05/2013. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-051928 · doc4.xml · nonDerivative · entry 3

Smith Sherrell · CIK 0001371105 · EVP, Admissions and Operations

10b5-1 filing: Not disclosed

Ownership: Indirect · spouse

Disclosed balance after: 19,954

F2 · shares: Vesting of Restricted Stock Units granted on 09/05/2013. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-051928 · doc4.xml · nonDerivative · entry 2

Smith Sherrell · CIK 0001371105 · EVP, Admissions and Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 161,002

F2 · shares: Vesting of Restricted Stock Units granted on 09/05/2013. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-051918 · doc4.xml · nonDerivative · entry 2

Peterson Bryce H · CIK 0001537809 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,091

F2 · shares: Vesting of Restricted Stock Units granted on 09/05/2013. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-051921 · doc4.xml · nonDerivative · entry 1

Turner Rhonda R · CIK 0001493754 · SVP People Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,989

F1 · shares: Vesting of Restricted Stock Units granted on 09/04/2014. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-051973 · doc4.xml · nonDerivative · entry 1

MCWATERS KIMBERLY J · CIK 0001272480 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 617,670

F1 · shares: Vesting of Restricted Stock Units granted on 09/04/2014. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-051958 · doc4.xml · nonDerivative · entry 1

Freed Chad Allen · CIK 0001319172 · EVP, Gen Counsel & Corp Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,084

F1 · shares: Vesting of Restricted Stock Units granted on 09/04/2014. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-051928 · doc4.xml · nonDerivative · entry 1

Smith Sherrell · CIK 0001371105 · EVP, Admissions and Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 162,846

F1 · shares: Vesting of Restricted Stock Units granted on 09/04/2014. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-051918 · doc4.xml · nonDerivative · entry 1

Peterson Bryce H · CIK 0001537809 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,381

F1 · shares: Vesting of Restricted Stock Units granted on 09/04/2014. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-049296 · doc4.xml · nonDerivative · entry 1

MCWATERS KIMBERLY J · CIK 0001272480 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 626,412

F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2017.

SEC source: 0001209191-17-039860 · doc4.xml · nonDerivative · entry 1

Freed Chad Allen · CIK 0001319172 · EVP, Gen Counsel & Corp Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,886

F1 · shares: Vesting of Restricted Stock Units granted on 06/09/2015. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-040106 · doc4.xml · nonDerivative · entry 1

Smith Sherrell · CIK 0001371105 · EVP, Admissions and Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,602

F1 · shares: Vesting of Restricted Stock Units granted on 06/09/2015. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-038733 · doc4.xml · nonDerivative · entry 1

DEVINCENZI ROBERT THOMAS · CIK 0001226186 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,262

F1 · shares: The award was approved by the Compensation Committee of UTI's Board of Directors on June 7, 2017. UTI's Board of Directors approved the award on June 8, 2017.

SEC source: 0001209191-17-038625 · doc4.xml · nonDerivative · entry 1

Peterson Bryce H · CIK 0001537809 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,624

F1 · shares: Vesting of Restricted Stock granted on 06/05/2012, shares withheld to satisfy tax liability.

SEC source: 0001209191-17-034736 · doc4.xml · nonDerivative · entry 1

Blaszkiewicz David · CIK 0001536971 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,567

F1 · price: The transaction was executed in multiple trades at prices ranging from $3.52 to $3.69. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001076204-17-000007 · primary_doc.xml · nonDerivative · entry 5

STADIUM CAPITAL PARTNERS L P · CIK 0001076204 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,405,964

SEC source: 0001076204-17-000007 · primary_doc.xml · nonDerivative · entry 4

STADIUM CAPITAL PARTNERS L P · CIK 0001076204 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,415,673

SEC source: 0001076204-17-000007 · primary_doc.xml · nonDerivative · entry 3

STADIUM CAPITAL PARTNERS L P · CIK 0001076204 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,651,588

SEC source: 0001076204-17-000007 · primary_doc.xml · nonDerivative · entry 2

STADIUM CAPITAL PARTNERS L P · CIK 0001076204 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,692,419

SEC source: 0001076204-17-000007 · primary_doc.xml · nonDerivative · entry 1

STADIUM CAPITAL PARTNERS L P · CIK 0001076204 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,873,882

SEC source: 0001076204-17-000006 · primary_doc.xml · nonDerivative · entry 2

STADIUM CAPITAL PARTNERS L P · CIK 0001076204 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,882,955

SEC source: 0001076204-17-000006 · primary_doc.xml · nonDerivative · entry 1

STADIUM CAPITAL PARTNERS L P · CIK 0001076204 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,883,227

SEC source: 0001209191-17-016900 · doc4.xml · nonDerivative · entry 1

PENSKE ROGER S · CIK 0000942439 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,650

F1 · shares: The award was approved by the Compensation Committee of UTI's Board of Directors on February 28, 2017. UTI's Board of Directors approved the award on March 1, 2017.

SEC source: 0001209191-17-016896 · doc4.xml · nonDerivative · entry 1

CONRAD A CONRAD · CIK 0001181846 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,503

F1 · shares: The award was approved by the Compensation Committee of UTI's Board of Directors on February 28, 2017. UTI's Board of Directors approved the award on March 1, 2017.

SEC source: 0001209191-17-016874 · doc4.xml · nonDerivative · entry 1

SRERE LINDA J · CIK 0001193863 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,503

F1 · shares: The award was approved by the Compensation Committee of UTI's Board of Directors on February 28, 2017. UTI's Board of Directors approved the award on March 1, 2017.

SEC source: 0001209191-17-016802 · doc4.xml · nonDerivative · entry 1

Jameson Piper P · CIK 0001534143 · EVP & Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,834

F1 · shares: The Board of Directors approved the grant on March 1, 2017. The restricted stock units vest in four equal annual installments.

SEC source: 0001209191-17-016820 · doc4.xml · nonDerivative · entry 1

WHITE JOHN C · CIK 0001272479 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,838

F1 · shares: The award was approved by the Compensation Committee of UTI's Board of Directors on February 28, 2017. UTI's Board of Directors approved the award on March 1, 2017.